BINDS - Basis for Supporting Innovative Drug Discovery and Life Science . . . The BINDS program (Basis for Supporting Innovative Drug Discovery and Life Science Research), has been running since April 2017 The objective of this program is to establish an innovative platform to expedite the therapeutic applications of early-stage drug discovery and medical technology advances, by providing and sharing key technological infrastructure, including: synchrotron facilities